STOCKHOLM, Sweden--(BUSINESS WIRE)--Regulatory News: In less than a year, animal allergenicity testing for the production of cosmetics in the European Union will be banned, leaving only a limited time to find alternative methods to avoid further exemptions. Biovator, a Sweden-based biotech company, is developing a solution to part of the problem with its test tube based technology – the in Vitro CPA test. Government investment agency, ALMI Företagspartner AB, in conjunction with owners LinkMed, has decided to provide funding to further develop the procedure, which uses human tissue to identify substances that cause allergic reactions.
